INCMGA00012 in Combination With Other Therapies in Patients With Advanced Solid Tumors

Exclusion Criteria

• •Receipt of anticancer therapy within 21 days of the first administration of study treatment, with the exception of localized radiotherapy.
• •Toxicity of prior therapy that has not recovered to ≤ Grade 1 or baseline (with the exception of alopecia and anemia not requiring transfusional support).
• •Laboratory values outside the protocol-defined range at screening.
• •Active autoimmune disease requiring systemic immunosuppression in excess of physiologic maintenance doses of corticosteroids.
• •Known hypersensitivity to any of the study drugs, excipients, or another monoclonal antibody which cannot be controlled with standard measures (eg, antihistamines and corticosteroids).
• •Evidence of interstitial lung disease or active, noninfectious pneumonitis.